Research Paper Volume 11, Issue 14 pp 4900—4909
Osteoprotegerin as a biomarker of geriatric frailty syndrome
Figure 2. The relationship between OPG and frailty in subjects without fracture (A) and in patients with hip fracture (B).
Figure 2. The relationship between OPG and frailty in subjects without fracture (A) and in patients with hip fracture (B).